Citations

Clear

6273 citation(s) found for "To, Andrew".

Endovascular Treatment as a Bridge to Successful Surgical Revascularization for Chronic Mesenteric Ischemia
Oldenburg, W. Andrew, Paz‐Fumagalli, Ricardo , McKinney, J. Mark , Hakaim, Albert G., Biebl, Matthias

Mayo Clinic

The American Surgeon | November 29, 2022 | Volume: 70 | Issue: 11 | Pages: 994-998

10.1177/000313480407001113 Get It

Chronic mesenteric ischemia (CMI) can be treated with surgical revascularization or with angioplasty and stenting. As experience has been gained, endovascular treatment appears safe and effective in selected patients. Currently, surgical revascularization has better success and patency rates but also a higher short- and midterm mortality and morbidity, especially in patients at high surgical risk. A 72-year-old female with severe respiratory dysfunction presented with CMI resulting in profound malnutrition. Serial percutaneous interventions averted urgent surgery and reversed the mesenteric ischemia. Nine months later, after repeated angioplasty and stenting had failed, elective uncomplicated iliomesenteric bypass, in a medically optimized patient, resolved the ischemia. At an 18-month follow-up, the graft remained widely patent and the patient asymptomatic with a body weight corresponding to her ideal body weight. Compared to surgical revascularization, reocclusion or restenosis occurs more frequently after endovascular treatment of CMI, and reintervention may be necessary. Nevertheless, percutaneous intervention effectively provides relief from mesenteric ischemia and has lower perioperative complication rates compared to surgery in patients at high surgical risk. After initial relief of the CMI, the patient's condition may improve, allowing for more definitive secondary surgical revascularization, if needed.
Enduring Responses after 1-Year, Fixed-Duration Cevostamab Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Early Experience from a Phase I Study
Trudel, Suzanne , Spencer, Andrew , Forsberg, Peter A. , Laubach, Jacob P. , Mateos, María‐Victoria , Kaedbey, Rayan , Krishnan, Amrita , Choeurng, Voleak, Cooper, James Fenimore, Sumiyoshi, Teiko, Wong, Chihunt, Lesokhin, Alexander M. , Richter, Joshua , Cohen, Adam D. , Thomas, Sheeba K. , Bahlis, Nizar Jacques , Costa, Luciano J. , Rodríguez‐Otero, Paula , Berdeja, Jesús G. , Fonseca, Rafaël , Harrison, Simon J

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4415-4417

10.1182/blood-2022-157547 Get It

Frontline PET-Directed Therapy with Brentuximab Vedotin Plus AVD Followed By Nivolumab Consolidation in Patients with Limited Stage Hodgkin Lymphoma
Park, Steven I., Ansell, Stephen M. , Giri, Sharmila, Svoboda, Jakub , Smith, Stephen D. , Feldman, Tatyana , Budde, Elizabeth L., Ness, Andrew J, Choi, Yunsik , Bierman, Philip J., Lee, Hun Ju , Budde, Elizabeth L.

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1751-1752

10.1182/blood-2022-159258 Get It

Incidence of Second Primary Malignancies in Lymphoma Survivors: A Prospective Cohort Study in the Modern Treatment Era
Mwangi, Raphael , Nowakowski, Grzegorz S. , Thompson, Carrie A. , Desai, Sanjal H. , Wang, Yucai , Farooq, Umar , Mou, Eric , Feldman, Andrew L. , Syrbu, Sergei , Slager, Susan L. , Maurer, Matthew J. , Kay, Neil E. , Habermann, Thomas M. , Link, Brian K. , Cerhan, James R.

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1934-1936

10.1182/blood-2022-165207 Get It

The Impact of Momelotinib on Patient Reported Quality of Life for Symptomatic and Anemic Patients with Myelofibrosis: Results from the Phase 3 Momentum Study
Harrison, Claire , Palmer, Jeanne , Foltz, Lynda, Perkins, Andrew C. , Leahy, Michael F. , Ro, Sunhee , Donahue, Rafe, Deheshi, Samineh, Perkins, Andrew C , Mesa, Ruben A. , Gupta, Vikas , McLornan, Donal P. , McMullin, Mary Frances , Kiladjian, Jean‐Jacques , Platzbecker, Uwe , Fox, María Laura , Mead, Adam J. , Ross, David M , Oh, Stephen T. , Kawashima, Jun, Verstovšek, Srđan

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9677-9680

10.1182/blood-2022-162547 Get It

Genetic Determinants of Isolated and Systemic Testicular Diffuse Large B-Cell Lymphoma Highlight a Disease Spectrum
Boyle, Merrill, Meissner, Barbara , Mekwunye, Kelly, Slack, Graham W. , Farinha, Pedro , Villa, Diego , Cook, James R. , Farinha, Pedro , Wong, Jasper , Collinge, Brett , Hilton, Laura K. , Ben‐Neriah, Susana , Craig, Jeffrey W. , Sehn, Laurie H. , Gerrie, Alina S. , Mungall, Andrew J. , Steidl, Christian , Feldman, Andrew L. , Rimsza, Lisa M. , Savage, Kerry J. , Morin, Ryan D , Scott, David W.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6374-6375

10.1182/blood-2022-165546 Get It

The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification
Foran, James M. , Tandra, Anand, Mattour, Ahmad, Perkins, Andrew C. , Rodríguez‐Macías, Gabriela , Sibai, Hassan , Sun, Yan , Potluri, Jalaja , Harb, Jason G., How, Jonathan, Perkins, Andrew C , Passamonti, Francesco , Stefano, Valerio De , Fox, María Laura , McMullin, Mary Frances , Qin, Qin

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 583-585

10.1182/blood-2022-157949 Get It